SCHEMBL5183646

SCHEMBL5183646

O=C(c1ccc2oc3c(OC4CCCC4)cccc3c2c1)[N+](=O)[O-]

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 2/20 0.37
PDE4B Q07343 10/20 0.35
PDE4D Q08499 10/20 0.35
PDE4A P27815 9/20 0.35
PDE4C Q08493 9/20 0.35
PDE1A P54750 1/20 0.35
PDE1B Q01064 1/20 0.35
PDE1C Q14123 1/20 0.35
CYP19A1 P11511 2/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
TTR P02766 1/20 0.34
F2 P00734 1/20 0.33
PLG P00747 1/20 0.33
PLAU P00749 1/20 0.33
PLAT P00750 1/20 0.33
KLKB1 P03952 1/20 0.33
PRSS1 P07477 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5738370 0.82 MAOA (0.48) MEN1KMT2ANPSR1
SCHEMBL4561649 0.81 TTR (0.36) PDE4BPDE4DPDE4APDE4CTTR
SCHEMBL5183867 0.77 MAOA (0.46) TTR
SCHEMBL5016445 0.75 CYP19A1 (0.46) PDE5APDE4BPDE4DPDE4APDE4C
SCHEMBL4055340 0.67 CYP19A1 (0.43) CYP19A1CYP11B1CYP11B2MEN1KMT2A
SCHEMBL11766448 0.67 ACSL1 (0.47) PDE4BPDE4DPDE4APDE4CTTR
SCHEMBL11786003 0.65 TTR (0.43) PDE4BPDE4DPDE4APDE4CTTR
SCHEMBL11770574 0.64 TTR (0.36) PDE4BPDE4DPDE4APDE4CCYP19A1
SCHEMBL11767116 0.64 TTR (0.43) PDE4BPDE4DPDE4APDE4CTTR
SCHEMBL5022607 0.64 CYP19A1 (0.48) PDE4BPDE4DPDE4APDE4CCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799632-A2 PROCESS FOR THE PREPARATION OF N-(3,5-DICHLOROPYRID-4-YL)-4-DIFLUOROMETHOXY-8-METHANESULFONAMIDO-DIBENZO[B,D]FURAN-1-CARBOXAMIDE Glenmark Pharmaceuticals S.A. (CH) 2007-06-27 EP claimed
WO-2006040652-A2 PROCESS FOR THE PREPARATION OF N-(3,5-DICHLOROPYRID-4-YL)-4DIFLUOROMETHOXY-8-METHANESULFONAMIDO-DIBENZO[B,D]FURAN-1-CARBOXAMIDE GLENMARK PHARMACEUTICALS S.A. (US) 2006-04-20 WO claimed
EP-1799632-A2 PROCESS FOR THE PREPARATION OF N-(3,5-DICHLOROPYRID-4-YL)-4-DIFLUOROMETHOXY-8-METHANESULFONAMIDO-DIBENZO[B,D]FURAN-1-CARBOXAMIDE Glenmark Pharmaceuticals S.A. (CH) 2007-06-27 EP disclosed
WO-2006040652-A2 PROCESS FOR THE PREPARATION OF N-(3,5-DICHLOROPYRID-4-YL)-4DIFLUOROMETHOXY-8-METHANESULFONAMIDO-DIBENZO[B,D]FURAN-1-CARBOXAMIDE GLENMARK PHARMACEUTICALS S.A. (US) 2006-04-20 WO disclosed
EP-1620429-A1 NOVEL HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Glenmark Pharmaceuticals S.A. (CH) 2006-02-01 EP disclosed
EP-1554262-A1 NOVEL TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Glenmark Pharmaceuticals Limited (IN) 2005-07-20 EP disclosed
WO-2004089940-A1 NOVEL HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLENMARK PHARMACEUTICALS S.A. (US) 2004-10-21 WO disclosed
WO-2004037805-A1 NOVEL TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLENMARK PHARMACEUTICALS LTD. (US) 2004-05-06 WO disclosed